| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.98 | 0.004 | 0.982 | Antiinflammatory | 0.975 0.004 DBMET02859 0.951 0.004 DBMET02860 0.951 0.004 DBMET02861 0.982 0.004 DBMET00627 0.976 0.004 DBMET02863 0.976 0.004 DBMET02864 0.908 0.005 DBMET02862 0.977 0.004 DBMET02848 0.96 0.004 DBMET02849 0.96 0.004 DBMET02850 0.98 0.004 DBMET02851 0.98 0.004 DBMET02853 0.956 0.004 DBMET02852 0.956 0.004 DBMET02854 0.976 0.004 DBMET02856 0.956 0.004 DBMET02857 0.941 0.005 DBMET02855 0.941 0.005 DBMET02858 | DBMET00627 | |
| 0.902 | 0.002 | 0.968 | Androgen antagonist | 0.872 0.002 DBMET02859 0.68 0.003 DBMET02860 0.68 0.003 DBMET02861 0.968 0.001 DBMET00627 0.744 0.002 DBMET02863 0.744 0.002 DBMET02864 0.695 0.003 DBMET02862 0.956 0.002 DBMET02848 0.806 0.002 DBMET02849 0.806 0.002 DBMET02850 0.829 0.002 DBMET02851 0.829 0.002 DBMET02853 0.577 0.003 DBMET02852 0.577 0.003 DBMET02854 0.928 0.002 DBMET02856 0.577 0.003 DBMET02857 0.708 0.003 DBMET02855 0.708 0.003 DBMET02858 | DBMET00627 | |
| 0.901 | 0.002 | 0.95 | Hypoxia-inducible factor 1 alpha inhibitor | 0.851 0.003 DBMET02859 0.767 0.004 DBMET02860 0.767 0.004 DBMET02861 0.95 0.002 DBMET00627 0.827 0.003 DBMET02863 0.827 0.003 DBMET02864 0.657 0.005 DBMET02862 0.904 0.002 DBMET02848 0.81 0.003 DBMET02849 0.81 0.003 DBMET02850 0.859 0.003 DBMET02851 0.859 0.003 DBMET02853 0.73 0.004 DBMET02852 0.73 0.004 DBMET02854 0.817 0.003 DBMET02856 0.73 0.004 DBMET02857 0.687 0.005 DBMET02855 0.687 0.005 DBMET02858 | DBMET00627 | |
| 0.898 | 0.006 | 0.931 | Transcription factor NF kappa B inhibitor | 0.833 0.011 DBMET02859 0.796 0.013 DBMET02860 0.796 0.013 DBMET02861 0.922 0.004 DBMET00627 0.907 0.005 DBMET02863 0.907 0.005 DBMET02864 0.789 0.014 DBMET02862 0.881 0.008 DBMET02848 0.853 0.01 DBMET02849 0.853 0.01 DBMET02850 0.915 0.005 DBMET02851 0.915 0.005 DBMET02853 0.832 0.011 DBMET02852 0.832 0.011 DBMET02854 0.931 0.004 DBMET02856 0.832 0.011 DBMET02857 0.873 0.008 DBMET02855 0.873 0.008 DBMET02858 | DBMET02856 | |
| 0.842 | 0.002 | 0.904 | Antipruritic | 0.811 0.002 DBMET02859 0.542 0.004 DBMET02860 0.542 0.004 DBMET02861 0.904 0.002 DBMET00627 0.72 0.003 DBMET02863 0.72 0.003 DBMET02864 0.316 0.012 DBMET02862 0.879 0.002 DBMET02848 0.683 0.003 DBMET02849 0.683 0.003 DBMET02850 0.804 0.002 DBMET02851 0.804 0.002 DBMET02853 0.461 0.005 DBMET02852 0.461 0.005 DBMET02854 0.741 0.003 DBMET02856 0.461 0.005 DBMET02857 0.377 0.008 DBMET02855 0.377 0.008 DBMET02858 | DBMET00627 | |
| 0.84 | 0 | 0.899 | Transcortin receptor antagonist | 0.368 0 DBMET02859 0.246 0 DBMET02860 0.246 0 DBMET02861 0.899 0 DBMET00627 0.824 0 DBMET02863 0.824 0 DBMET02864 0.103 0 DBMET02862 0.611 0 DBMET02848 0.367 0 DBMET02849 0.367 0 DBMET02850 0.824 0 DBMET02851 0.824 0 DBMET02853 0.184 0 DBMET02852 0.184 0 DBMET02854 0.791 0 DBMET02856 0.184 0 DBMET02857 0.137 0 DBMET02855 0.137 0 DBMET02858 | DBMET00627 | |
| 0.841 | 0.005 | 0.89 | Toll-Like receptor 7 agonist | 0.828 0.005 DBMET02859 0.793 0.005 DBMET02860 0.793 0.005 DBMET02861 0.89 0.004 DBMET00627 0.816 0.005 DBMET02863 0.816 0.005 DBMET02864 0.592 0.018 DBMET02862 0.881 0.005 DBMET02848 0.864 0.005 DBMET02849 0.864 0.005 DBMET02850 0.878 0.005 DBMET02851 0.878 0.005 DBMET02853 0.85 0.005 DBMET02852 0.85 0.005 DBMET02854 0.821 0.005 DBMET02856 0.85 0.005 DBMET02857 0.77 0.005 DBMET02855 0.77 0.005 DBMET02858 | DBMET00627 | |
| 0.838 | 0.005 | 0.888 | Toll-Like receptor agonist | 0.824 0.005 DBMET02859 0.794 0.005 DBMET02860 0.794 0.005 DBMET02861 0.888 0.004 DBMET00627 0.811 0.005 DBMET02863 0.811 0.005 DBMET02864 0.596 0.018 DBMET02862 0.878 0.005 DBMET02848 0.865 0.005 DBMET02849 0.865 0.005 DBMET02850 0.876 0.005 DBMET02851 0.876 0.005 DBMET02853 0.85 0.005 DBMET02852 0.85 0.005 DBMET02854 0.815 0.005 DBMET02856 0.85 0.005 DBMET02857 0.769 0.005 DBMET02855 0.769 0.005 DBMET02858 | DBMET00627 | |
| 0.828 | 0.001 | 0.879 | Aromatase inhibitor | 0.82 0.002 DBMET02859 0.561 0.003 DBMET02860 0.561 0.003 DBMET02861 0.761 0.002 DBMET00627 0.879 0.001 DBMET02863 0.879 0.001 DBMET02864 0.477 0.003 DBMET02862 0.752 0.002 DBMET02848 0.465 0.004 DBMET02849 0.465 0.004 DBMET02850 0.8 0.002 DBMET02851 0.8 0.002 DBMET02853 0.518 0.003 DBMET02852 0.518 0.003 DBMET02854 0.658 0.002 DBMET02856 0.518 0.003 DBMET02857 0.325 0.005 DBMET02855 0.325 0.005 DBMET02858 | DBMET02864 | |
| 0.774 | 0.001 | 0.879 | Androgen agonist | 0.671 0.001 DBMET02859 0.765 0.001 DBMET02860 0.765 0.001 DBMET02861 0.879 0.001 DBMET00627 0.669 0.001 DBMET02863 0.669 0.001 DBMET02864 0.767 0.001 DBMET02862 0.8 0.001 DBMET02848 0.855 0.001 DBMET02849 0.855 0.001 DBMET02850 0.672 0.001 DBMET02851 0.672 0.001 DBMET02853 0.632 0.001 DBMET02852 0.632 0.001 DBMET02854 0.803 0.001 DBMET02856 0.632 0.001 DBMET02857 0.768 0.001 DBMET02855 0.768 0.001 DBMET02858 | DBMET00627 | |
| 0.767 | 0.001 | 0.79 | Glucocorticoid agonist | 0.729 0.001 DBMET02859 0.429 0.001 DBMET02860 0.429 0.001 DBMET02861 0.79 0.001 DBMET00627 0.702 0.001 DBMET02863 0.702 0.001 DBMET02864 0.26 0.002 DBMET02862 0.765 0.001 DBMET02848 0.587 0.001 DBMET02849 0.587 0.001 DBMET02850 0.765 0.001 DBMET02851 0.765 0.001 DBMET02853 0.472 0.001 DBMET02852 0.472 0.001 DBMET02854 0.748 0.001 DBMET02856 0.472 0.001 DBMET02857 0.396 0.001 DBMET02855 0.396 0.001 DBMET02858 | DBMET00627 | |
| 0.775 | 0.02 | 0.802 | Apoptosis agonist | 0.743 0.024 DBMET02859 0.699 0.031 DBMET02860 0.699 0.031 DBMET02861 0.768 0.02 DBMET00627 0.749 0.023 DBMET02863 0.749 0.023 DBMET02864 0.714 0.028 DBMET02862 0.737 0.025 DBMET02848 0.699 0.031 DBMET02849 0.699 0.031 DBMET02850 0.743 0.024 DBMET02851 0.743 0.024 DBMET02853 0.671 0.035 DBMET02852 0.671 0.035 DBMET02854 0.802 0.016 DBMET02856 0.671 0.035 DBMET02857 0.733 0.025 DBMET02855 0.733 0.025 DBMET02858 | DBMET02856 | |
| 0.739 | 0.004 | 0.773 | Immunosuppressant | 0.724 0.005 DBMET02859 0.742 0.004 DBMET02860 0.742 0.004 DBMET02861 0.77 0.004 DBMET00627 0.727 0.005 DBMET02863 0.727 0.005 DBMET02864 0.711 0.005 DBMET02862 0.756 0.004 DBMET02848 0.773 0.004 DBMET02849 0.773 0.004 DBMET02850 0.76 0.004 DBMET02851 0.76 0.004 DBMET02853 0.764 0.004 DBMET02852 0.764 0.004 DBMET02854 0.732 0.004 DBMET02856 0.764 0.004 DBMET02857 0.737 0.004 DBMET02855 0.737 0.004 DBMET02858 | DBMET02850 | |
| 0.73 | 0.006 | 0.73 | Aldehyde oxidase inhibitor | 0.604 0.018 DBMET02859 0.701 0.008 DBMET02860 0.701 0.008 DBMET02861 0.726 0.006 DBMET00627 0.635 0.014 DBMET02863 0.635 0.014 DBMET02864 0.537 0.028 DBMET02862 0.599 0.019 DBMET02848 0.687 0.009 DBMET02849 0.687 0.009 DBMET02850 0.635 0.014 DBMET02851 0.635 0.014 DBMET02853 0.59 0.02 DBMET02852 0.59 0.02 DBMET02854 0.513 0.031 DBMET02856 0.59 0.02 DBMET02857 0.436 0.042 DBMET02855 0.436 0.042 DBMET02858 | ||
| 0.693 | 0.006 | 0.736 | Nitric oxide antagonist | 0.642 0.008 DBMET02859 0.638 0.008 DBMET02860 0.638 0.008 DBMET02861 0.566 0.012 DBMET00627 0.736 0.005 DBMET02863 0.736 0.005 DBMET02864 0.615 0.009 DBMET02862 0.518 0.015 DBMET02848 0.517 0.015 DBMET02849 0.517 0.015 DBMET02850 0.616 0.009 DBMET02851 0.616 0.009 DBMET02853 0.57 0.011 DBMET02852 0.57 0.011 DBMET02854 0.584 0.01 DBMET02856 0.57 0.011 DBMET02857 0.535 0.013 DBMET02855 0.535 0.013 DBMET02858 | DBMET02864 | |
| 0.671 | 0.001 | 0.792 | Glucocorticoid antagonist | 0.514 0.002 DBMET02859 0.342 0.002 DBMET02860 0.342 0.002 DBMET02861 0.792 0.001 DBMET00627 0.489 0.002 DBMET02863 0.489 0.002 DBMET02864 0.291 0.003 DBMET02862 0.644 0.002 DBMET02848 0.465 0.002 DBMET02849 0.465 0.002 DBMET02850 0.662 0.001 DBMET02851 0.662 0.001 DBMET02853 0.365 0.002 DBMET02852 0.365 0.002 DBMET02854 0.672 0.001 DBMET02856 0.365 0.002 DBMET02857 0.362 0.002 DBMET02855 0.362 0.002 DBMET02858 | DBMET00627 | |
| 0.657 | 0.001 | 0.678 | Interferon gamma antagonist | 0.616 0.002 DBMET02859 0.602 0.002 DBMET02860 0.602 0.002 DBMET02861 0.678 0.001 DBMET00627 0.633 0.002 DBMET02863 0.633 0.002 DBMET02864 0.579 0.003 DBMET02862 0.636 0.002 DBMET02848 0.617 0.002 DBMET02849 0.617 0.002 DBMET02850 0.63 0.002 DBMET02851 0.63 0.002 DBMET02853 0.568 0.003 DBMET02852 0.568 0.003 DBMET02854 0.641 0.002 DBMET02856 0.568 0.003 DBMET02857 0.58 0.003 DBMET02855 0.58 0.003 DBMET02858 | DBMET00627 | |
| 0.655 | 0.004 | 0.684 | Anesthetic general | 0.584 0.005 DBMET02859 0.552 0.005 DBMET02860 0.552 0.005 DBMET02861 0.5 0.008 DBMET00627 0.615 0.004 DBMET02863 0.615 0.004 DBMET02864 0.684 0.004 DBMET02862 0.421 0.014 DBMET02848 0.381 0.019 DBMET02849 0.381 0.019 DBMET02850 0.403 0.016 DBMET02851 0.403 0.016 DBMET02853 0.279 0.039 DBMET02852 0.279 0.039 DBMET02854 0.673 0.004 DBMET02856 0.279 0.039 DBMET02857 0.564 0.005 DBMET02855 0.564 0.005 DBMET02858 | DBMET02862 | |
| 0.654 | 0.012 | 0.748 | Cholesterol antagonist | 0.572 0.022 DBMET02859 0.679 0.01 DBMET02860 0.679 0.01 DBMET02861 0.575 0.022 DBMET00627 0.634 0.014 DBMET02863 0.634 0.014 DBMET02864 0.748 0.005 DBMET02862 0.451 0.04 DBMET02848 0.599 0.019 DBMET02849 0.599 0.019 DBMET02850 0.466 0.038 DBMET02851 0.466 0.038 DBMET02853 0.5 0.033 DBMET02852 0.5 0.033 DBMET02854 0.633 0.014 DBMET02856 0.5 0.033 DBMET02857 0.65 0.012 DBMET02855 0.65 0.012 DBMET02858 | DBMET02862 | |
| 0.621 | 0.002 | 0.719 | Lipocortins synthesis antagonist | 0.629 0.002 DBMET02859 0.605 0.002 DBMET02860 0.605 0.002 DBMET02861 0.715 0.001 DBMET00627 0.587 0.002 DBMET02863 0.587 0.002 DBMET02864 0.564 0.003 DBMET02862 0.719 0.001 DBMET02848 0.702 0.001 DBMET02849 0.702 0.001 DBMET02850 0.689 0.001 DBMET02851 0.689 0.001 DBMET02853 0.677 0.001 DBMET02852 0.677 0.001 DBMET02854 0.674 0.001 DBMET02856 0.677 0.001 DBMET02857 0.662 0.001 DBMET02855 0.662 0.001 DBMET02858 | DBMET02848 | |
| 0.56 | 0.005 | 0.746 | Diuretic | 0.542 0.006 DBMET02859 0.584 0.005 DBMET02860 0.584 0.005 DBMET02861 0.732 0.004 DBMET00627 0.428 0.011 DBMET02863 0.428 0.011 DBMET02864 0.46 0.009 DBMET02862 0.72 0.004 DBMET02848 0.746 0.003 DBMET02849 0.746 0.003 DBMET02850 0.639 0.004 DBMET02851 0.639 0.004 DBMET02853 0.661 0.004 DBMET02852 0.661 0.004 DBMET02854 0.553 0.005 DBMET02856 0.661 0.004 DBMET02857 0.575 0.005 DBMET02855 0.575 0.005 DBMET02858 | DBMET02850 | |
| 0.552 | 0.005 | 0.632 | P-glycoprotein inhibitor | 0.511 0.008 DBMET02859 0.279 0.033 DBMET02860 0.279 0.033 DBMET02861 0.602 0.005 DBMET00627 0.607 0.005 DBMET02863 0.607 0.005 DBMET02864 0.27 0.036 DBMET02862 0.561 0.005 DBMET02848 0.35 0.021 DBMET02849 0.35 0.021 DBMET02850 0.632 0.004 DBMET02851 0.632 0.004 DBMET02853 0.431 0.013 DBMET02852 0.431 0.013 DBMET02854 0.624 0.005 DBMET02856 0.431 0.013 DBMET02857 0.401 0.016 DBMET02855 0.401 0.016 DBMET02858 | DBMET02853 | |
| 0.52 | 0.002 | 0.751 | Progesterone antagonist | 0.53 0.002 DBMET02859 0.26 0.004 DBMET02860 0.26 0.004 DBMET02861 0.745 0.001 DBMET00627 0.39 0.003 DBMET02863 0.39 0.003 DBMET02864 0.176 0.005 DBMET02862 0.751 0.001 DBMET02848 0.482 0.002 DBMET02849 0.482 0.002 DBMET02850 0.656 0.002 DBMET02851 0.656 0.002 DBMET02853 0.368 0.003 DBMET02852 0.368 0.003 DBMET02854 0.55 0.002 DBMET02856 0.368 0.003 DBMET02857 0.279 0.004 DBMET02855 0.279 0.004 DBMET02858 | DBMET02848 | |
| 0.48 | 0.015 | 0.584 | DNA synthesis inhibitor | 0.416 0.02 DBMET02859 0.394 0.022 DBMET02860 0.394 0.022 DBMET02861 0.584 0.008 DBMET00627 0.478 0.015 DBMET02863 0.478 0.015 DBMET02864 0.278 0.052 DBMET02862 0.537 0.011 DBMET02848 0.507 0.013 DBMET02849 0.507 0.013 DBMET02850 0.542 0.011 DBMET02851 0.542 0.011 DBMET02853 0.458 0.016 DBMET02852 0.458 0.016 DBMET02854 0.48 0.015 DBMET02856 0.458 0.016 DBMET02857 0.383 0.024 DBMET02855 0.383 0.024 DBMET02858 | DBMET00627 | |
| 0.464 | 0 | 0.517 | Corticosteroid-like | 0.369 0.001 DBMET02859 0.186 0.001 DBMET02860 0.186 0.001 DBMET02861 0.517 0 DBMET00627 0.333 0.001 DBMET02863 0.333 0.001 DBMET02864 0.13 0.001 DBMET02862 0.436 0 DBMET02848 0.248 0.001 DBMET02849 0.248 0.001 DBMET02850 0.437 0 DBMET02851 0.437 0 DBMET02853 0.189 0.001 DBMET02852 0.189 0.001 DBMET02854 0.415 0 DBMET02856 0.189 0.001 DBMET02857 0.169 0.001 DBMET02855 0.169 0.001 DBMET02858 | DBMET00627 | |
| 0.468 | 0.005 | 0.509 | NOS3 expression enhancer | 0.317 0.015 DBMET02859 0.289 0.019 DBMET02860 0.289 0.019 DBMET02861 0.509 0.005 DBMET00627 0.37 0.01 DBMET02863 0.37 0.01 DBMET02864 0.173 0.054 DBMET02862 0.357 0.011 DBMET02848 0.335 0.013 DBMET02849 0.335 0.013 DBMET02850 0.404 0.008 DBMET02851 0.404 0.008 DBMET02853 0.246 0.027 DBMET02852 0.246 0.027 DBMET02854 0.407 0.008 DBMET02856 0.246 0.027 DBMET02857 0.24 0.029 DBMET02855 0.24 0.029 DBMET02858 | DBMET00627 | |
| 0.461 | 0 | 0.509 | Arachidonic acid antagonist | 0.398 0 DBMET02859 0.359 0.001 DBMET02860 0.359 0.001 DBMET02861 0.509 0 DBMET00627 0.442 0 DBMET02863 0.442 0 DBMET02864 0.335 0.001 DBMET02862 0.43 0 DBMET02848 0.376 0.001 DBMET02849 0.376 0.001 DBMET02850 0.445 0 DBMET02851 0.445 0 DBMET02853 0.346 0.001 DBMET02852 0.346 0.001 DBMET02854 0.429 0 DBMET02856 0.346 0.001 DBMET02857 0.337 0.001 DBMET02855 0.337 0.001 DBMET02858 | DBMET00627 | |
| 0.449 | 0.002 | 0.69 | Aldosterone antagonist | 0.443 0.002 DBMET02859 0.273 0.003 DBMET02860 0.273 0.003 DBMET02861 0.69 0.001 DBMET00627 0.265 0.003 DBMET02863 0.265 0.003 DBMET02864 0.088 0.009 DBMET02862 0.685 0.001 DBMET02848 0.507 0.002 DBMET02849 0.507 0.002 DBMET02850 0.497 0.002 DBMET02851 0.497 0.002 DBMET02853 0.325 0.003 DBMET02852 0.325 0.003 DBMET02854 0.404 0.002 DBMET02856 0.325 0.003 DBMET02857 0.22 0.004 DBMET02855 0.22 0.004 DBMET02858 | DBMET00627 | |
| 0.447 | 0.005 | 0.536 | Interleukin 6 antagonist | 0.411 0.007 DBMET02859 0.243 0.024 DBMET02860 0.243 0.024 DBMET02861 0.535 0.004 DBMET00627 0.451 0.005 DBMET02863 0.451 0.005 DBMET02864 0.255 0.022 DBMET02862 0.493 0.005 DBMET02848 0.368 0.009 DBMET02849 0.368 0.009 DBMET02850 0.536 0.004 DBMET02851 0.536 0.004 DBMET02853 0.375 0.009 DBMET02852 0.375 0.009 DBMET02854 0.499 0.005 DBMET02856 0.375 0.009 DBMET02857 0.321 0.012 DBMET02855 0.321 0.012 DBMET02858 | DBMET02853 | |
| 0.442 | 0.008 | 0.541 | Lipid peroxidase inhibitor | 0.397 0.01 DBMET02859 0.506 0.005 DBMET02860 0.506 0.005 DBMET02861 0.486 0.005 DBMET00627 0.349 0.013 DBMET02863 0.349 0.013 DBMET02864 0.367 0.011 DBMET02862 0.456 0.007 DBMET02848 0.541 0.005 DBMET02849 0.541 0.005 DBMET02850 0.422 0.009 DBMET02851 0.422 0.009 DBMET02853 0.493 0.005 DBMET02852 0.493 0.005 DBMET02854 0.325 0.016 DBMET02856 0.493 0.005 DBMET02857 0.414 0.009 DBMET02855 0.414 0.009 DBMET02858 | DBMET02850 | |
| 0.439 | 0.009 | 0.507 | Sodium/bile acid cotransporter inhibitor | 0.415 0.013 DBMET02859 0.441 0.009 DBMET02860 0.441 0.009 DBMET02861 0.482 0.005 DBMET00627 0.459 0.006 DBMET02863 0.459 0.006 DBMET02864 0.488 0.004 DBMET02862 0.465 0.006 DBMET02848 0.482 0.005 DBMET02849 0.482 0.005 DBMET02850 0.494 0.004 DBMET02851 0.494 0.004 DBMET02853 0.494 0.004 DBMET02852 0.494 0.004 DBMET02854 0.507 0.004 DBMET02856 0.494 0.004 DBMET02857 0.507 0.004 DBMET02855 0.507 0.004 DBMET02858 | DBMET02858 | |
| 0.403 | 0.002 | 0.403 | 5-Alpha-reductase inhibitor | 0.396 0.002 DBMET02859 0.396 0.002 DBMET02860 0.396 0.002 DBMET02861 0.398 0.002 DBMET00627 0.326 0.003 DBMET02863 0.326 0.003 DBMET02864 0.399 0.002 DBMET02862 0.389 0.002 DBMET02848 0.392 0.002 DBMET02849 0.392 0.002 DBMET02850 0.322 0.003 DBMET02851 0.322 0.003 DBMET02853 0.316 0.003 DBMET02852 0.316 0.003 DBMET02854 0.378 0.002 DBMET02856 0.316 0.003 DBMET02857 0.37 0.002 DBMET02855 0.37 0.002 DBMET02858 | ||
| 0.357 | 0.013 | 0.357 | Topoisomerase II inhibitor | 0.334 0.014 DBMET02859 0.337 0.014 DBMET00627 0.312 0.016 DBMET02863 0.312 0.016 DBMET02864 0.315 0.016 DBMET02848 0.301 0.018 DBMET02851 0.301 0.018 DBMET02853 0.26 0.023 DBMET02856 | ||
| 0.382 | 0.038 | 0.512 | Antioxidant | 0.332 0.051 DBMET02859 0.503 0.02 DBMET02860 0.503 0.02 DBMET02861 0.398 0.035 DBMET00627 0.385 0.037 DBMET02863 0.385 0.037 DBMET02864 0.493 0.021 DBMET02862 0.349 0.047 DBMET02848 0.511 0.019 DBMET02849 0.511 0.019 DBMET02850 0.387 0.037 DBMET02851 0.387 0.037 DBMET02853 0.5 0.02 DBMET02852 0.5 0.02 DBMET02854 0.396 0.036 DBMET02856 0.5 0.02 DBMET02857 0.512 0.019 DBMET02855 0.512 0.019 DBMET02858 | DBMET02858 | |
| 0.343 | 0.005 | 0.377 | Estrogen antagonist | 0.286 0.007 DBMET02859 0.237 0.009 DBMET02860 0.237 0.009 DBMET02861 0.377 0.005 DBMET00627 0.274 0.007 DBMET02863 0.274 0.007 DBMET02864 0.205 0.012 DBMET02862 0.32 0.005 DBMET02848 0.274 0.007 DBMET02849 0.274 0.007 DBMET02850 0.32 0.005 DBMET02851 0.32 0.005 DBMET02853 0.229 0.01 DBMET02852 0.229 0.01 DBMET02854 0.31 0.006 DBMET02856 0.229 0.01 DBMET02857 0.218 0.011 DBMET02855 0.218 0.011 DBMET02858 | DBMET00627 | |
| 0.371 | 0.035 | 0.503 | Interleukin antagonist | 0.296 0.049 DBMET02859 0.169 0.104 DBMET02860 0.169 0.104 DBMET02861 0.503 0.02 DBMET00627 0.286 0.051 DBMET02863 0.286 0.051 DBMET02864 0.443 0.025 DBMET02848 0.33 0.042 DBMET02849 0.33 0.042 DBMET02850 0.441 0.025 DBMET02851 0.441 0.025 DBMET02853 0.258 0.059 DBMET02852 0.258 0.059 DBMET02854 0.399 0.031 DBMET02856 0.258 0.059 DBMET02857 0.202 0.083 DBMET02855 0.202 0.083 DBMET02858 | DBMET00627 | |
| 0.334 | 0.001 | 0.552 | Anabolic | 0.297 0.001 DBMET02859 0.417 0.001 DBMET02860 0.417 0.001 DBMET02861 0.431 0.001 DBMET00627 0.313 0.001 DBMET02863 0.313 0.001 DBMET02864 0.388 0.001 DBMET02862 0.369 0.001 DBMET02848 0.552 0.001 DBMET02849 0.552 0.001 DBMET02850 0.317 0.001 DBMET02851 0.317 0.001 DBMET02853 0.364 0.001 DBMET02852 0.364 0.001 DBMET02854 0.355 0.001 DBMET02856 0.364 0.001 DBMET02857 0.416 0.001 DBMET02855 0.416 0.001 DBMET02858 | DBMET02850 | |
| 0.306 | 0.007 | 0.306 | Topoisomerase II alpha inhibitor | 0.289 0.008 DBMET02859 0.301 0.007 DBMET00627 0.264 0.009 DBMET02863 0.264 0.009 DBMET02864 0.284 0.008 DBMET02848 0.264 0.009 DBMET02851 0.264 0.009 DBMET02853 0.281 0.008 DBMET02856 | ||
| 0.299 | 0.001 | 0.425 | Lipocortins synthesis agonist | 0.245 0.001 DBMET02859 0.183 0.001 DBMET02860 0.183 0.001 DBMET02861 0.425 0 DBMET00627 0.237 0.001 DBMET02863 0.237 0.001 DBMET02864 0.15 0.002 DBMET02862 0.364 0 DBMET02848 0.231 0.001 DBMET02849 0.231 0.001 DBMET02850 0.369 0 DBMET02851 0.369 0 DBMET02853 0.21 0.001 DBMET02852 0.21 0.001 DBMET02854 0.295 0.001 DBMET02856 0.21 0.001 DBMET02857 0.186 0.001 DBMET02855 0.186 0.001 DBMET02858 | DBMET00627 | |
| 0.296 | 0.005 | 0.296 | Estrogen agonist | 0.166 0.01 DBMET02859 0.281 0.005 DBMET02860 0.281 0.005 DBMET02861 0.273 0.005 DBMET00627 0.24 0.007 DBMET02863 0.24 0.007 DBMET02864 0.284 0.005 DBMET02862 0.155 0.011 DBMET02848 0.264 0.006 DBMET02849 0.264 0.006 DBMET02850 0.224 0.007 DBMET02851 0.224 0.007 DBMET02853 0.215 0.007 DBMET02852 0.215 0.007 DBMET02854 0.259 0.006 DBMET02856 0.215 0.007 DBMET02857 0.249 0.006 DBMET02855 0.249 0.006 DBMET02858 | ||
| 0.348 | 0.057 | 0.479 | Apoptosis antagonist | 0.313 0.077 DBMET02859 0.356 0.053 DBMET02860 0.356 0.053 DBMET02861 0.387 0.042 DBMET00627 0.438 0.029 DBMET02863 0.438 0.029 DBMET02864 0.376 0.046 DBMET02862 0.349 0.056 DBMET02848 0.395 0.04 DBMET02849 0.395 0.04 DBMET02850 0.472 0.024 DBMET02851 0.472 0.024 DBMET02853 0.479 0.023 DBMET02852 0.479 0.023 DBMET02854 0.391 0.041 DBMET02856 0.479 0.023 DBMET02857 0.398 0.039 DBMET02855 0.398 0.039 DBMET02858 | DBMET02857 | |
| 0.29 | 0.004 | 0.378 | Mineralocorticoid receptor antagonist | 0.26 0.004 DBMET02859 0.152 0.005 DBMET02860 0.152 0.005 DBMET02861 0.378 0.003 DBMET00627 0.177 0.004 DBMET02863 0.177 0.004 DBMET02864 0.133 0.005 DBMET02862 0.344 0.004 DBMET02848 0.242 0.004 DBMET02849 0.242 0.004 DBMET02850 0.289 0.004 DBMET02851 0.289 0.004 DBMET02853 0.17 0.005 DBMET02852 0.17 0.005 DBMET02854 0.312 0.004 DBMET02856 0.17 0.005 DBMET02857 0.181 0.004 DBMET02855 0.181 0.004 DBMET02858 | DBMET00627 | |
| 0.296 | 0.012 | 0.402 | Cholesterol synthesis inhibitor | 0.187 0.03 DBMET02859 0.383 0.005 DBMET02860 0.383 0.005 DBMET02861 0.331 0.008 DBMET00627 0.283 0.013 DBMET02863 0.283 0.013 DBMET02864 0.388 0.005 DBMET02862 0.228 0.021 DBMET02848 0.402 0.004 DBMET02849 0.402 0.004 DBMET02850 0.278 0.014 DBMET02851 0.278 0.014 DBMET02853 0.358 0.006 DBMET02852 0.358 0.006 DBMET02854 0.315 0.01 DBMET02856 0.358 0.006 DBMET02857 0.388 0.005 DBMET02855 0.388 0.005 DBMET02858 | DBMET02850 | |
| 0.304 | 0.029 | 0.379 | Hepatoprotectant | 0.293 0.032 DBMET02859 0.304 0.028 DBMET02860 0.304 0.028 DBMET02861 0.299 0.03 DBMET00627 0.337 0.021 DBMET02863 0.337 0.021 DBMET02864 0.37 0.016 DBMET02862 0.288 0.033 DBMET02848 0.297 0.03 DBMET02849 0.297 0.03 DBMET02850 0.316 0.025 DBMET02851 0.316 0.025 DBMET02853 0.314 0.026 DBMET02852 0.314 0.026 DBMET02854 0.379 0.015 DBMET02856 0.314 0.026 DBMET02857 0.375 0.016 DBMET02855 0.375 0.016 DBMET02858 | DBMET02856 | |
| 0.265 | 0.001 | 0.265 | Glucose-6-phosphate dehydrogenase inhibitor | 0.157 0.002 DBMET02859 0.094 0.003 DBMET02860 0.094 0.003 DBMET02861 0.132 0.002 DBMET00627 0.224 0.002 DBMET02863 0.224 0.002 DBMET02864 0.114 0.003 DBMET02862 0.103 0.003 DBMET02848 0.065 0.006 DBMET02849 0.065 0.006 DBMET02850 0.132 0.002 DBMET02851 0.132 0.002 DBMET02853 0.066 0.005 DBMET02852 0.066 0.005 DBMET02854 0.14 0.002 DBMET02856 0.066 0.005 DBMET02857 0.068 0.005 DBMET02855 0.068 0.005 DBMET02858 | ||
| 0.265 | 0.005 | 0.265 | Inducible nitric-oxide synthase inhibitor | 0.172 0.012 DBMET02859 0.091 0.046 DBMET02860 0.091 0.046 DBMET02861 0.188 0.01 DBMET00627 0.203 0.008 DBMET02863 0.203 0.008 DBMET02864 0.089 0.048 DBMET02862 0.112 0.028 DBMET02848 0.159 0.014 DBMET02851 0.159 0.014 DBMET02853 0.171 0.012 DBMET02856 | ||
| 0.258 | 0.005 | 0.676 | Interleukin 8 antagonist | 0.146 0.037 DBMET02859 0.15 0.034 DBMET02860 0.15 0.034 DBMET02861 0.676 0.003 DBMET00627 0.16 0.028 DBMET02863 0.16 0.028 DBMET02864 0.32 0.004 DBMET02848 0.348 0.004 DBMET02849 0.348 0.004 DBMET02850 0.359 0.004 DBMET02851 0.359 0.004 DBMET02853 0.203 0.012 DBMET02852 0.203 0.012 DBMET02854 0.253 0.005 DBMET02856 0.203 0.012 DBMET02857 0.152 0.033 DBMET02855 0.152 0.033 DBMET02858 | DBMET00627 | |
| 0.26 | 0.01 | 0.36 | Farnesoid X receptor antagonist | 0.181 0.029 DBMET02859 0.246 0.012 DBMET02860 0.246 0.012 DBMET02861 0.29 0.007 DBMET00627 0.244 0.012 DBMET02863 0.244 0.012 DBMET02864 0.296 0.006 DBMET02862 0.221 0.016 DBMET02848 0.28 0.008 DBMET02849 0.28 0.008 DBMET02850 0.277 0.008 DBMET02851 0.277 0.008 DBMET02853 0.267 0.009 DBMET02852 0.267 0.009 DBMET02854 0.36 0.004 DBMET02856 0.267 0.009 DBMET02857 0.351 0.004 DBMET02855 0.351 0.004 DBMET02858 | DBMET02856 | |
| 0.246 | 0.002 | 0.288 | Progesterone agonist | 0.288 0.002 DBMET02859 0.166 0.003 DBMET02860 0.166 0.003 DBMET02861 0.22 0.002 DBMET00627 0.192 0.002 DBMET02863 0.192 0.002 DBMET02864 0.178 0.002 DBMET02862 0.263 0.002 DBMET02848 0.162 0.003 DBMET02849 0.162 0.003 DBMET02850 0.197 0.002 DBMET02851 0.197 0.002 DBMET02853 0.145 0.003 DBMET02852 0.145 0.003 DBMET02854 0.22 0.002 DBMET02856 0.145 0.003 DBMET02857 0.161 0.003 DBMET02855 0.161 0.003 DBMET02858 | DBMET02859 | |
| 0.307 | 0.069 | 0.368 | Interleukin 2 agonist | 0.351 0.045 DBMET02860 0.351 0.045 DBMET02861 0.333 0.054 DBMET00627 0.264 0.104 DBMET02863 0.264 0.104 DBMET02864 0.298 0.075 DBMET02862 0.23 0.143 DBMET02848 0.368 0.038 DBMET02849 0.368 0.038 DBMET02850 0.264 0.104 DBMET02851 0.264 0.104 DBMET02853 0.307 0.069 DBMET02852 0.307 0.069 DBMET02854 0.267 0.1 DBMET02856 0.307 0.069 DBMET02857 0.311 0.066 DBMET02855 0.311 0.066 DBMET02858 | DBMET02850 | |
| 0.268 | 0.029 | 0.28 | Neurotrophic factor enhancer | 0.227 0.054 DBMET02859 0.254 0.036 DBMET02860 0.254 0.036 DBMET02861 0.28 0.024 DBMET00627 0.273 0.027 DBMET02863 0.273 0.027 DBMET02864 0.259 0.034 DBMET02862 0.238 0.046 DBMET02848 0.263 0.032 DBMET02849 0.263 0.032 DBMET02850 0.273 0.027 DBMET02851 0.273 0.027 DBMET02853 0.256 0.035 DBMET02852 0.256 0.035 DBMET02854 0.262 0.032 DBMET02856 0.256 0.035 DBMET02857 0.246 0.041 DBMET02855 0.246 0.041 DBMET02858 | DBMET00627 | |
| 0.249 | 0.014 | 0.293 | Antineoplastic antibiotic | 0.258 0.013 DBMET02859 0.234 0.016 DBMET02860 0.234 0.016 DBMET02861 0.241 0.015 DBMET00627 0.293 0.01 DBMET02863 0.293 0.01 DBMET02864 0.261 0.013 DBMET02862 0.25 0.014 DBMET02848 0.225 0.017 DBMET02849 0.225 0.017 DBMET02850 0.269 0.012 DBMET02851 0.269 0.012 DBMET02853 0.254 0.014 DBMET02852 0.254 0.014 DBMET02854 0.278 0.011 DBMET02856 0.254 0.014 DBMET02857 0.262 0.013 DBMET02855 0.262 0.013 DBMET02858 | DBMET02864 | |
| 0.229 | 0.003 | 0.229 | 5-Alpha-reductase 1 inhibitor | 0.197 0.003 DBMET02859 0.222 0.003 DBMET02860 0.222 0.003 DBMET02861 0.193 0.003 DBMET00627 0.091 0.005 DBMET02863 0.091 0.005 DBMET02864 0.219 0.003 DBMET02862 0.166 0.003 DBMET02848 0.195 0.003 DBMET02849 0.195 0.003 DBMET02850 0.085 0.005 DBMET02851 0.085 0.005 DBMET02853 0.087 0.005 DBMET02852 0.087 0.005 DBMET02854 0.139 0.004 DBMET02856 0.087 0.005 DBMET02857 0.142 0.004 DBMET02855 0.142 0.004 DBMET02858 | ||
| 0.348 | 0.124 | 0.382 | Cyclophilin D inhibitor | 0.268 0.193 DBMET02859 0.338 0.131 DBMET02860 0.338 0.131 DBMET02861 0.382 0.101 DBMET00627 0.342 0.128 DBMET02863 0.342 0.128 DBMET02864 0.339 0.131 DBMET02862 0.309 0.154 DBMET02848 0.358 0.117 DBMET02849 0.358 0.117 DBMET02850 0.321 0.145 DBMET02851 0.321 0.145 DBMET02853 0.297 0.165 DBMET02852 0.297 0.165 DBMET02854 0.365 0.112 DBMET02856 0.297 0.165 DBMET02857 0.34 0.13 DBMET02855 0.34 0.13 DBMET02858 | DBMET00627 | |
| 0.225 | 0.003 | 0.25 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.17 0.004 DBMET02859 0.25 0.003 DBMET02860 0.25 0.003 DBMET02861 0.131 0.004 DBMET00627 0.134 0.004 DBMET02863 0.134 0.004 DBMET02864 0.109 0.004 DBMET02862 0.092 0.005 DBMET02848 0.132 0.004 DBMET02849 0.132 0.004 DBMET02850 0.037 0.008 DBMET02851 0.037 0.008 DBMET02853 0.037 0.008 DBMET02852 0.037 0.008 DBMET02854 0.066 0.005 DBMET02856 0.037 0.008 DBMET02857 0.067 0.005 DBMET02855 0.067 0.005 DBMET02858 | DBMET02861 | |
| 0.235 | 0.018 | 0.432 | Alkylator | 0.227 0.02 DBMET02859 0.145 0.049 DBMET02860 0.145 0.049 DBMET02861 0.432 0.006 DBMET00627 0.265 0.015 DBMET02863 0.265 0.015 DBMET02864 0.102 0.086 DBMET02862 0.419 0.007 DBMET02848 0.261 0.015 DBMET02849 0.261 0.015 DBMET02850 0.422 0.007 DBMET02851 0.422 0.007 DBMET02853 0.251 0.016 DBMET02852 0.251 0.016 DBMET02854 0.289 0.013 DBMET02856 0.251 0.016 DBMET02857 0.169 0.037 DBMET02855 0.169 0.037 DBMET02858 | DBMET00627 | |
| 0.219 | 0.005 | 0.329 | Interleukin 5 antagonist | 0.169 0.008 DBMET02859 0.153 0.01 DBMET02860 0.153 0.01 DBMET02861 0.329 0.004 DBMET00627 0.163 0.009 DBMET02863 0.163 0.009 DBMET02864 0.083 0.066 DBMET02862 0.239 0.005 DBMET02848 0.215 0.005 DBMET02849 0.215 0.005 DBMET02850 0.239 0.005 DBMET02851 0.239 0.005 DBMET02853 0.169 0.008 DBMET02852 0.169 0.008 DBMET02854 0.182 0.007 DBMET02856 0.169 0.008 DBMET02857 0.132 0.017 DBMET02855 0.132 0.017 DBMET02858 | DBMET00627 | |
| 0.355 | 0.141 | 0.661 | Caspase 9 stimulant | 0.287 0.209 DBMET02859 0.351 0.145 DBMET02860 0.351 0.145 DBMET02861 0.478 0.069 DBMET00627 0.398 0.112 DBMET02863 0.398 0.112 DBMET02864 0.514 0.054 DBMET02862 0.4 0.111 DBMET02848 0.465 0.075 DBMET02849 0.465 0.075 DBMET02850 0.474 0.071 DBMET02851 0.474 0.071 DBMET02853 0.461 0.077 DBMET02852 0.461 0.077 DBMET02854 0.661 0.028 DBMET02856 0.461 0.077 DBMET02857 0.636 0.031 DBMET02855 0.636 0.031 DBMET02858 | DBMET02856 | |
| 0.294 | 0.08 | 0.395 | Immunostimulant | 0.243 0.099 DBMET02859 0.24 0.101 DBMET02860 0.24 0.101 DBMET02861 0.395 0.051 DBMET00627 0.271 0.088 DBMET02863 0.271 0.088 DBMET02864 0.225 0.107 DBMET02862 0.36 0.062 DBMET02848 0.344 0.066 DBMET02849 0.344 0.066 DBMET02850 0.332 0.07 DBMET02851 0.332 0.07 DBMET02853 0.26 0.092 DBMET02852 0.26 0.092 DBMET02854 0.365 0.06 DBMET02856 0.26 0.092 DBMET02857 0.299 0.079 DBMET02855 0.299 0.079 DBMET02858 | DBMET00627 | |
| 0.229 | 0.016 | 0.287 | Interleukin 4 antagonist | 0.219 0.018 DBMET02859 0.141 0.058 DBMET02860 0.141 0.058 DBMET02861 0.287 0.009 DBMET00627 0.182 0.029 DBMET02863 0.182 0.029 DBMET02864 0.276 0.01 DBMET02848 0.18 0.03 DBMET02849 0.18 0.03 DBMET02850 0.215 0.019 DBMET02851 0.215 0.019 DBMET02853 0.137 0.064 DBMET02852 0.137 0.064 DBMET02854 0.179 0.03 DBMET02856 0.137 0.064 DBMET02857 | DBMET00627 | |
| 0.226 | 0.02 | 0.24 | DNA intercalator | 0.195 0.027 DBMET02859 0.24 0.018 DBMET00627 0.187 0.029 DBMET02863 0.187 0.029 DBMET02864 0.208 0.024 DBMET02848 0.203 0.025 DBMET02851 0.203 0.025 DBMET02853 0.202 0.025 DBMET02856 | DBMET00627 | |
| 0.194 | 0.003 | 0.273 | RNA-directed RNA polymerase stimulant | 0.094 0.007 DBMET02859 0.185 0.003 DBMET02860 0.185 0.003 DBMET02861 0.203 0.003 DBMET00627 0.142 0.004 DBMET02863 0.142 0.004 DBMET02864 0.273 0.002 DBMET02862 0.106 0.006 DBMET02848 0.194 0.003 DBMET02849 0.194 0.003 DBMET02850 0.142 0.004 DBMET02851 0.142 0.004 DBMET02853 0.136 0.004 DBMET02852 0.136 0.004 DBMET02854 0.222 0.003 DBMET02856 0.136 0.004 DBMET02857 0.213 0.003 DBMET02855 0.213 0.003 DBMET02858 | DBMET02862 | |
| 0.193 | 0.003 | 0.241 | 5-Alpha-reductase 2 inhibitor | 0.155 0.004 DBMET02859 0.23 0.003 DBMET02860 0.23 0.003 DBMET02861 0.167 0.004 DBMET00627 0.078 0.006 DBMET02863 0.078 0.006 DBMET02864 0.241 0.002 DBMET02862 0.133 0.004 DBMET02848 0.213 0.003 DBMET02849 0.213 0.003 DBMET02850 0.058 0.007 DBMET02851 0.058 0.007 DBMET02853 0.112 0.005 DBMET02852 0.112 0.005 DBMET02854 0.128 0.004 DBMET02856 0.112 0.005 DBMET02857 0.173 0.003 DBMET02855 0.173 0.003 DBMET02858 | DBMET02862 | |
| 0.191 | 0.002 | 0.191 | Heme oxygenase stimulant | 0.185 0.002 DBMET02859 0.18 0.002 DBMET02860 0.18 0.002 DBMET02861 0.116 0.005 DBMET00627 0.173 0.002 DBMET02863 0.173 0.002 DBMET02864 0.135 0.003 DBMET02862 0.112 0.005 DBMET02848 0.111 0.005 DBMET02849 0.111 0.005 DBMET02850 0.111 0.005 DBMET02851 0.111 0.005 DBMET02853 0.106 0.006 DBMET02852 0.106 0.006 DBMET02854 0.066 0.032 DBMET02856 0.106 0.006 DBMET02857 0.061 0.042 DBMET02855 0.061 0.042 DBMET02858 | ||
| 0.201 | 0.013 | 0.223 | Antineoplastic alkaloid | 0.18 0.019 DBMET02859 0.194 0.015 DBMET02860 0.194 0.015 DBMET02861 0.223 0.008 DBMET00627 0.204 0.013 DBMET02863 0.204 0.013 DBMET02864 0.178 0.02 DBMET02862 0.21 0.011 DBMET02848 0.217 0.009 DBMET02849 0.217 0.009 DBMET02850 0.221 0.009 DBMET02851 0.221 0.009 DBMET02853 0.216 0.01 DBMET02852 0.216 0.01 DBMET02854 0.207 0.012 DBMET02856 0.216 0.01 DBMET02857 0.201 0.014 DBMET02855 0.201 0.014 DBMET02858 | DBMET00627 | |
| 0.188 | 0.01 | 0.222 | Transcription factor NF kappa B stimulant | 0.183 0.011 DBMET02859 0.222 0.007 DBMET02860 0.222 0.007 DBMET02861 0.144 0.017 DBMET00627 0.192 0.01 DBMET02863 0.192 0.01 DBMET02864 0.166 0.013 DBMET02862 0.141 0.018 DBMET02848 0.174 0.012 DBMET02849 0.174 0.012 DBMET02850 0.146 0.017 DBMET02851 0.146 0.017 DBMET02853 0.176 0.012 DBMET02852 0.176 0.012 DBMET02854 0.104 0.035 DBMET02856 0.176 0.012 DBMET02857 0.129 0.021 DBMET02855 0.129 0.021 DBMET02858 | DBMET02861 | |
| 0.224 | 0.055 | 0.401 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.161 0.124 DBMET02859 0.401 0.008 DBMET00627 0.199 0.073 DBMET02863 0.199 0.073 DBMET02864 0.331 0.016 DBMET02848 0.3 0.024 DBMET02849 0.3 0.024 DBMET02850 0.333 0.015 DBMET02851 0.333 0.015 DBMET02853 0.222 0.056 DBMET02852 0.222 0.056 DBMET02854 0.37 0.01 DBMET02856 0.222 0.056 DBMET02857 0.268 0.035 DBMET02855 0.268 0.035 DBMET02858 | DBMET00627 | |
| 0.242 | 0.085 | 0.342 | DNA damaging | 0.224 0.097 DBMET02859 0.342 0.043 DBMET00627 0.184 0.13 DBMET02863 0.184 0.13 DBMET02864 0.319 0.05 DBMET02848 0.247 0.082 DBMET02851 0.247 0.082 DBMET02853 0.188 0.126 DBMET02856 | DBMET00627 | |
| 0.196 | 0.042 | 0.247 | Melanin inhibitor | 0.153 0.078 DBMET02859 0.217 0.035 DBMET02860 0.217 0.035 DBMET02861 0.227 0.033 DBMET00627 0.161 0.068 DBMET02863 0.161 0.068 DBMET02864 0.181 0.051 DBMET02862 0.168 0.061 DBMET02848 0.247 0.029 DBMET02849 0.247 0.029 DBMET02850 0.158 0.072 DBMET02851 0.158 0.072 DBMET02853 0.165 0.064 DBMET02852 0.165 0.064 DBMET02854 0.173 0.057 DBMET02856 0.165 0.064 DBMET02857 0.181 0.051 DBMET02855 0.181 0.051 DBMET02858 | DBMET02850 | |
| 0.165 | 0.014 | 0.213 | Toll-Like receptor 4 antagonist | 0.153 0.019 DBMET02859 0.213 0.005 DBMET02860 0.213 0.005 DBMET02861 0.169 0.013 DBMET00627 0.162 0.015 DBMET02863 0.162 0.015 DBMET02864 0.186 0.008 DBMET02862 0.158 0.017 DBMET02848 0.213 0.005 DBMET02849 0.213 0.005 DBMET02850 0.162 0.015 DBMET02851 0.162 0.015 DBMET02853 0.206 0.005 DBMET02852 0.206 0.005 DBMET02854 0.138 0.028 DBMET02856 0.206 0.005 DBMET02857 0.192 0.007 DBMET02855 0.192 0.007 DBMET02858 | DBMET02850 | |
| 0.154 | 0.005 | 0.179 | Estrogen receptor alpha agonist | 0.084 0.011 DBMET02859 0.149 0.005 DBMET02860 0.149 0.005 DBMET02861 0.179 0.005 DBMET00627 0.1 0.009 DBMET02863 0.1 0.009 DBMET02864 0.137 0.005 DBMET02862 0.096 0.009 DBMET02848 0.175 0.005 DBMET02849 0.175 0.005 DBMET02850 0.112 0.007 DBMET02851 0.112 0.007 DBMET02853 0.111 0.007 DBMET02852 0.111 0.007 DBMET02854 0.136 0.005 DBMET02856 0.111 0.007 DBMET02857 0.133 0.006 DBMET02855 0.133 0.006 DBMET02858 | DBMET00627 | |
| 0.155 | 0.014 | 0.164 | Estrogen receptor beta antagonist | 0.127 0.025 DBMET02859 0.133 0.021 DBMET02860 0.133 0.021 DBMET02861 0.164 0.013 DBMET00627 0.132 0.022 DBMET02863 0.132 0.022 DBMET02864 0.132 0.022 DBMET02862 0.132 0.022 DBMET02848 0.139 0.019 DBMET02849 0.139 0.019 DBMET02850 0.141 0.018 DBMET02851 0.141 0.018 DBMET02853 0.126 0.026 DBMET02852 0.126 0.026 DBMET02854 0.146 0.016 DBMET02856 0.126 0.026 DBMET02857 0.129 0.024 DBMET02855 0.129 0.024 DBMET02858 | DBMET00627 | |
| 0.172 | 0.04 | 0.489 | Monophenol monooxygenase inhibitor | 0.105 0.072 DBMET02859 0.225 0.028 DBMET02860 0.225 0.028 DBMET02861 0.386 0.012 DBMET00627 0.12 0.061 DBMET02863 0.12 0.061 DBMET02864 0.107 0.071 DBMET02862 0.253 0.024 DBMET02848 0.489 0.008 DBMET02849 0.489 0.008 DBMET02850 0.274 0.021 DBMET02851 0.274 0.021 DBMET02853 0.342 0.014 DBMET02852 0.342 0.014 DBMET02854 0.2 0.033 DBMET02856 0.342 0.014 DBMET02857 0.258 0.023 DBMET02855 0.258 0.023 DBMET02858 | DBMET02850 | |
| 0.138 | 0.009 | 0.172 | Na+ K+ transporting ATPase inhibitor | 0.118 0.017 DBMET02859 0.145 0.007 DBMET02860 0.145 0.007 DBMET02861 0.147 0.006 DBMET00627 0.139 0.008 DBMET02863 0.139 0.008 DBMET02864 0.158 0.005 DBMET02862 0.126 0.013 DBMET02848 0.152 0.005 DBMET02849 0.152 0.005 DBMET02850 0.139 0.008 DBMET02851 0.139 0.008 DBMET02853 0.143 0.007 DBMET02852 0.143 0.007 DBMET02854 0.166 0.004 DBMET02856 0.143 0.007 DBMET02857 0.172 0.003 DBMET02855 0.172 0.003 DBMET02858 | DBMET02858 | |
| 0.243 | 0.118 | 0.469 | Caspase 3 stimulant | 0.239 0.123 DBMET02859 0.292 0.083 DBMET00627 0.349 0.059 DBMET02863 0.349 0.059 DBMET02864 0.285 0.087 DBMET02862 0.285 0.087 DBMET02848 0.384 0.049 DBMET02851 0.384 0.049 DBMET02853 0.232 0.129 DBMET02852 0.232 0.129 DBMET02854 0.469 0.025 DBMET02856 0.232 0.129 DBMET02857 0.33 0.066 DBMET02855 0.33 0.066 DBMET02858 | DBMET02856 | |
| 0.155 | 0.031 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.153 0.036 DBMET02859 0.137 0.085 DBMET02860 0.137 0.085 DBMET02861 0.163 0.02 DBMET00627 0.158 0.026 DBMET02863 0.158 0.026 DBMET02864 0.141 0.069 DBMET02862 0.16 0.023 DBMET02848 0.141 0.069 DBMET02849 0.141 0.069 DBMET02850 0.158 0.026 DBMET02851 0.158 0.026 DBMET02853 0.137 0.085 DBMET02852 0.137 0.085 DBMET02854 0.163 0.02 DBMET02856 0.137 0.085 DBMET02857 0.141 0.069 DBMET02855 0.141 0.069 DBMET02858 | DBMET02856 | |
| 0.128 | 0.004 | 0.128 | Estrone sulfatase inhibitor | 0.054 0.007 DBMET02859 0.096 0.005 DBMET02860 0.096 0.005 DBMET02861 0.114 0.004 DBMET00627 0.079 0.005 DBMET02863 0.079 0.005 DBMET02864 0.063 0.006 DBMET02862 0.048 0.008 DBMET02848 0.085 0.005 DBMET02849 0.085 0.005 DBMET02850 0.079 0.005 DBMET02851 0.079 0.005 DBMET02853 0.06 0.006 DBMET02852 0.06 0.006 DBMET02854 0.067 0.005 DBMET02856 0.06 0.006 DBMET02857 0.053 0.007 DBMET02855 0.053 0.007 DBMET02858 | ||
| 0.119 | 0.004 | 0.125 | Nitric oxide donor | 0.114 0.004 DBMET02859 0.097 0.01 DBMET02860 0.097 0.01 DBMET02861 0.125 0.004 DBMET00627 0.114 0.004 DBMET02863 0.114 0.004 DBMET02864 0.066 0.039 DBMET02862 0.12 0.004 DBMET02848 0.107 0.006 DBMET02849 0.107 0.006 DBMET02850 0.121 0.004 DBMET02851 0.121 0.004 DBMET02853 0.101 0.008 DBMET02852 0.101 0.008 DBMET02854 0.115 0.004 DBMET02856 0.101 0.008 DBMET02857 0.088 0.015 DBMET02855 0.088 0.015 DBMET02858 | DBMET00627 | |
| 0.158 | 0.045 | 0.181 | DNA polymerase I inhibitor | 0.117 0.07 DBMET02859 0.163 0.043 DBMET02860 0.163 0.043 DBMET02861 0.181 0.035 DBMET00627 0.16 0.044 DBMET02863 0.16 0.044 DBMET02864 0.153 0.048 DBMET02862 0.144 0.052 DBMET02848 0.179 0.035 DBMET02849 0.179 0.035 DBMET02850 0.16 0.044 DBMET02851 0.16 0.044 DBMET02853 0.159 0.044 DBMET02852 0.159 0.044 DBMET02854 0.159 0.044 DBMET02856 0.159 0.044 DBMET02857 0.158 0.045 DBMET02855 0.158 0.045 DBMET02858 | DBMET00627 | |
| 0.115 | 0.01 | 0.133 | Estrogen receptor beta agonist | 0.05 0.019 DBMET02859 0.114 0.01 DBMET02860 0.114 0.01 DBMET02861 0.133 0.008 DBMET00627 0.07 0.016 DBMET02863 0.07 0.016 DBMET02864 0.113 0.01 DBMET02862 0.075 0.015 DBMET02848 0.13 0.009 DBMET02849 0.13 0.009 DBMET02850 0.088 0.013 DBMET02851 0.088 0.013 DBMET02853 0.086 0.013 DBMET02852 0.086 0.013 DBMET02854 0.115 0.01 DBMET02856 0.086 0.013 DBMET02857 0.113 0.01 DBMET02855 0.113 0.01 DBMET02858 | DBMET00627 | |
| 0.126 | 0.034 | 0.126 | Nitric-oxide synthase inhibitor | |||
| 0.108 | 0.023 | 0.237 | Estrogen receptor alpha antagonist | 0.074 0.058 DBMET02859 0.103 0.025 DBMET02860 0.103 0.025 DBMET02861 0.237 0.006 DBMET00627 0.094 0.031 DBMET02863 0.094 0.031 DBMET02864 0.107 0.023 DBMET02862 0.122 0.018 DBMET02848 0.213 0.008 DBMET02849 0.213 0.008 DBMET02850 0.166 0.01 DBMET02851 0.166 0.01 DBMET02853 0.149 0.012 DBMET02852 0.149 0.012 DBMET02854 0.195 0.008 DBMET02856 0.149 0.012 DBMET02857 0.171 0.01 DBMET02855 0.171 0.01 DBMET02858 | DBMET00627 | |
| 0.094 | 0.012 | 0.094 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.058 0.031 DBMET02859 0.076 0.018 DBMET02860 0.076 0.018 DBMET02861 0.086 0.014 DBMET00627 0.048 0.046 DBMET02863 0.048 0.046 DBMET02864 0.053 0.038 DBMET02848 0.071 0.021 DBMET02849 0.071 0.021 DBMET02850 0.048 0.046 DBMET02851 0.048 0.046 DBMET02853 | ||
| 0.088 | 0.012 | 0.14 | Estradiol 17 beta-dehydrogenase inhibitor | 0.038 0.033 DBMET02859 0.089 0.012 DBMET02860 0.089 0.012 DBMET02861 0.139 0.007 DBMET00627 0.053 0.023 DBMET02863 0.053 0.023 DBMET02864 0.087 0.012 DBMET02862 0.06 0.019 DBMET02848 0.14 0.007 DBMET02849 0.14 0.007 DBMET02850 0.076 0.014 DBMET02851 0.076 0.014 DBMET02853 0.077 0.014 DBMET02852 0.077 0.014 DBMET02854 0.097 0.011 DBMET02856 0.077 0.014 DBMET02857 0.097 0.011 DBMET02855 0.097 0.011 DBMET02858 | DBMET02850 | |
| 0.073 | 0.005 | 0.073 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.034 0.02 DBMET02859 0.059 0.008 DBMET02860 0.059 0.008 DBMET02861 0.062 0.008 DBMET00627 0.039 0.016 DBMET02863 0.039 0.016 DBMET02864 0.045 0.013 DBMET02862 0.029 0.026 DBMET02848 0.052 0.01 DBMET02849 0.052 0.01 DBMET02850 0.039 0.016 DBMET02851 0.039 0.016 DBMET02853 0.033 0.022 DBMET02852 0.033 0.022 DBMET02854 0.037 0.017 DBMET02856 0.033 0.022 DBMET02857 0.031 0.023 DBMET02855 0.031 0.023 DBMET02858 | ||
| 0.096 | 0.029 | 0.105 | T cell inhibitor | 0.094 0.032 DBMET02859 0.105 0.02 DBMET00627 0.088 0.042 DBMET02863 0.088 0.042 DBMET02864 0.103 0.022 DBMET02848 0.083 0.055 DBMET02849 0.083 0.055 DBMET02850 0.093 0.032 DBMET02851 0.093 0.032 DBMET02853 0.087 0.043 DBMET02856 | DBMET00627 | |
| 0.079 | 0.016 | 0.114 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.114 0.009 DBMET02859 0.044 0.035 DBMET02860 0.044 0.035 DBMET02861 0.049 0.03 DBMET00627 0.067 0.02 DBMET02863 0.067 0.02 DBMET02864 0.071 0.019 DBMET02862 0.074 0.017 DBMET02848 0.044 0.035 DBMET02851 0.044 0.035 DBMET02853 0.067 0.02 DBMET02856 | DBMET02859 | |
| 0.191 | 0.128 | 0.266 | Spasmolytic | 0.266 0.084 DBMET02859 0.21 0.111 DBMET02860 0.21 0.111 DBMET02861 0.184 0.134 DBMET02863 0.184 0.134 DBMET02864 0.209 0.112 DBMET02848 | DBMET02859 | |
| 0.154 | 0.097 | 0.185 | Phospholipase C inhibitor | 0.137 0.136 DBMET02860 0.137 0.136 DBMET02861 0.15 0.106 DBMET00627 0.185 0.056 DBMET02863 0.185 0.056 DBMET02864 0.159 0.09 DBMET02862 0.157 0.094 DBMET02851 0.157 0.094 DBMET02853 0.162 0.085 DBMET02856 0.138 0.132 DBMET02855 0.138 0.132 DBMET02858 | DBMET02864 | |
| 0.11 | 0.057 | 0.18 | Beta glucuronidase inhibitor | 0.093 0.082 DBMET02859 0.116 0.049 DBMET02860 0.116 0.049 DBMET02861 0.168 0.018 DBMET00627 0.144 0.028 DBMET02848 0.18 0.016 DBMET02849 0.18 0.016 DBMET02850 0.124 0.042 DBMET02851 0.124 0.042 DBMET02853 0.131 0.037 DBMET02852 0.131 0.037 DBMET02854 0.096 0.076 DBMET02856 0.131 0.037 DBMET02857 0.102 0.067 DBMET02855 0.102 0.067 DBMET02858 | DBMET02850 | |
| 0.083 | 0.035 | 0.099 | Glycine receptor agonist | 0.07 0.054 DBMET02860 0.07 0.054 DBMET02861 0.099 0.022 DBMET00627 0.067 0.062 DBMET02863 0.067 0.062 DBMET02864 0.078 0.041 DBMET02849 0.078 0.041 DBMET02850 0.067 0.062 DBMET02851 0.067 0.062 DBMET02853 0.074 0.047 DBMET02856 | DBMET00627 | |
| 0.107 | 0.064 | 0.123 | Topoisomerase I inhibitor | 0.092 0.077 DBMET02859 0.123 0.054 DBMET00627 0.095 0.075 DBMET02863 0.095 0.075 DBMET02864 0.108 0.064 DBMET02848 0.098 0.072 DBMET02851 0.098 0.072 DBMET02853 0.096 0.073 DBMET02856 | DBMET00627 | |
| 0.05 | 0.008 | 0.056 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.056 0.007 DBMET02859 0.025 0.022 DBMET02860 0.025 0.022 DBMET02861 0.049 0.009 DBMET00627 0.049 0.009 DBMET02863 0.049 0.009 DBMET02864 0.034 0.014 DBMET02862 0.054 0.008 DBMET02848 0.024 0.023 DBMET02849 0.024 0.023 DBMET02850 0.043 0.01 DBMET02851 0.043 0.01 DBMET02853 0.056 0.007 DBMET02856 0.028 0.019 DBMET02855 0.028 0.019 DBMET02858 | DBMET02856 | |
| 0.124 | 0.088 | 0.214 | Protein kinase stimulant | 0.214 0.037 DBMET02859 0.116 0.096 DBMET02860 0.116 0.096 DBMET02861 0.118 0.095 DBMET00627 0.147 0.07 DBMET02863 0.147 0.07 DBMET02864 0.134 0.08 DBMET02862 0.203 0.04 DBMET02848 0.132 0.081 DBMET02856 0.116 0.097 DBMET02855 0.116 0.097 DBMET02858 | DBMET02859 | |
| 0.106 | 0.07 | 0.106 | GABA receptor agonist | |||
| 0.23 | 0.196 | 0.425 | Antibacterial | 0.22 0.207 DBMET02859 0.296 0.138 DBMET02860 0.296 0.138 DBMET02861 0.28 0.151 DBMET00627 0.345 0.105 DBMET02863 0.345 0.105 DBMET02864 0.395 0.079 DBMET02862 0.268 0.16 DBMET02848 0.325 0.117 DBMET02849 0.325 0.117 DBMET02850 0.322 0.119 DBMET02851 0.322 0.119 DBMET02853 0.368 0.092 DBMET02852 0.368 0.092 DBMET02854 0.383 0.085 DBMET02856 0.368 0.092 DBMET02857 0.425 0.066 DBMET02855 0.425 0.066 DBMET02858 | DBMET02858 | |
| 0.085 | 0.052 | 0.085 | Estrogen-related receptor beta agonist | 0.077 0.076 DBMET02859 0.079 0.072 DBMET02860 0.079 0.072 DBMET02861 0.084 0.056 DBMET00627 0.079 0.07 DBMET02849 0.079 0.07 DBMET02850 | ||
| 0.06 | 0.032 | 0.06 | GABA receptor antagonist | |||
| 0.082 | 0.055 | 0.085 | Ca(v)3.1 blocker | 0.085 0.047 DBMET02859 | DBMET02859 | |
| 0.043 | 0.022 | 0.043 | GABA uptake inhibitor | 0.038 0.029 DBMET02859 0.038 0.03 DBMET02862 | ||
| 0.055 | 0.035 | 0.055 | GABA A receptor antagonist | |||
| 0.103 | 0.085 | 0.246 | Microtubule formation inhibitor | 0.135 0.047 DBMET02860 0.135 0.047 DBMET02861 0.182 0.024 DBMET00627 0.12 0.06 DBMET02863 0.12 0.06 DBMET02864 0.175 0.027 DBMET02862 0.146 0.04 DBMET02848 0.224 0.015 DBMET02849 0.224 0.015 DBMET02850 0.173 0.028 DBMET02851 0.173 0.028 DBMET02853 0.214 0.017 DBMET02852 0.214 0.017 DBMET02854 0.218 0.016 DBMET02856 0.214 0.017 DBMET02857 0.246 0.01 DBMET02855 0.246 0.01 DBMET02858 | DBMET02858 | |
| 0.056 | 0.04 | 0.065 | Pregnane X receptor antagonist | 0.059 0.032 DBMET02860 0.059 0.032 DBMET02861 0.055 0.046 DBMET00627 0.065 0.021 DBMET02862 0.057 0.039 DBMET02849 0.057 0.039 DBMET02850 0.062 0.025 DBMET02856 0.065 0.021 DBMET02855 0.065 0.021 DBMET02858 | DBMET02858 | |
| 0.11 | 0.095 | 0.141 | Bone formation stimulant | 0.141 0.066 DBMET00627 0.135 0.072 DBMET02849 0.135 0.072 DBMET02850 0.121 0.084 DBMET02856 0.113 0.092 DBMET02855 0.113 0.092 DBMET02858 | DBMET00627 | |
| 0.079 | 0.064 | 0.079 | GABA A receptor agonist | |||
| 0.124 | 0.114 | 0.181 | Adenylate cyclase stimulant | 0.15 0.062 DBMET02860 0.15 0.062 DBMET02861 0.161 0.046 DBMET00627 0.14 0.08 DBMET02863 0.14 0.08 DBMET02864 0.141 0.078 DBMET02862 0.148 0.066 DBMET02848 0.181 0.025 DBMET02849 0.181 0.025 DBMET02850 0.157 0.052 DBMET02851 0.157 0.052 DBMET02853 0.176 0.029 DBMET02852 0.176 0.029 DBMET02854 0.157 0.052 DBMET02856 0.176 0.029 DBMET02857 0.177 0.029 DBMET02855 0.177 0.029 DBMET02858 | DBMET02850 | |
| 0.015 | 0.005 | 0.017 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.014 0.005 DBMET02859 0.014 0.006 DBMET02860 0.014 0.006 DBMET02861 0.014 0.006 DBMET00627 0.014 0.006 DBMET02863 0.014 0.006 DBMET02864 0.017 0.004 DBMET02862 0.013 0.006 DBMET02848 0.013 0.007 DBMET02849 0.013 0.007 DBMET02850 0.014 0.006 DBMET02851 0.014 0.006 DBMET02853 0.013 0.007 DBMET02852 0.013 0.007 DBMET02854 0.016 0.004 DBMET02856 0.013 0.007 DBMET02857 0.016 0.004 DBMET02855 0.016 0.004 DBMET02858 | DBMET02862 | |
| 0.021 | 0.011 | 0.021 | Progesterone receptor B antagonist | 0.018 0.015 DBMET02859 0.019 0.015 DBMET02860 0.019 0.015 DBMET02861 0.019 0.014 DBMET00627 0.021 0.011 DBMET02862 0.018 0.017 DBMET02849 0.018 0.017 DBMET02850 0.021 0.011 DBMET02856 0.019 0.014 DBMET02855 0.019 0.014 DBMET02858 | ||
| 0.071 | 0.063 | 0.072 | Keratolytic | 0.069 0.067 DBMET02860 0.069 0.067 DBMET02861 0.072 0.061 DBMET00627 0.071 0.064 DBMET02849 0.071 0.064 DBMET02850 | DBMET00627 | |
| 0.083 | 0.077 | 0.083 | Prolactin inhibitor | |||
| 0.016 | 0.013 | 0.025 | Vitamin D receptor agonist | 0.018 0.008 DBMET02860 0.018 0.008 DBMET02861 0.016 0.012 DBMET00627 0.019 0.008 DBMET02863 0.019 0.008 DBMET02864 0.025 0.004 DBMET02862 0.018 0.009 DBMET02849 0.018 0.009 DBMET02850 0.016 0.012 DBMET02851 0.016 0.012 DBMET02853 0.018 0.009 DBMET02852 0.018 0.009 DBMET02854 0.019 0.007 DBMET02856 0.018 0.009 DBMET02857 0.022 0.005 DBMET02855 0.022 0.005 DBMET02858 | DBMET02862 | |
| 0.025 | 0.026 | 0.041 | Hedgehog signaling activator | 0.034 0.007 DBMET00627 0.028 0.018 DBMET02863 0.028 0.018 DBMET02864 0.026 0.025 DBMET02848 0.032 0.01 DBMET02849 0.032 0.01 DBMET02850 0.032 0.01 DBMET02851 0.032 0.01 DBMET02853 0.03 0.013 DBMET02852 0.03 0.013 DBMET02854 0.041 0.004 DBMET02856 0.03 0.013 DBMET02857 0.038 0.005 DBMET02855 0.038 0.005 DBMET02858 | DBMET02856 | |
| 0.075 | 0.078 | 0.079 | Thioredoxin reductase inhibitor | 0.078 0.069 DBMET02859 0.077 0.072 DBMET00627 0.079 0.064 DBMET02848 | DBMET02848 | |
| 0.068 | 0.08 | 0.104 | Glycine receptor antagonist | 0.104 0.029 DBMET00627 0.086 0.048 DBMET02849 0.086 0.048 DBMET02850 0.082 0.054 DBMET02851 0.082 0.054 DBMET02853 0.083 0.052 DBMET02856 | DBMET00627 | |
| 0.086 | 0.1 | 0.138 | Mucolytic | 0.097 0.082 DBMET02859 0.124 0.05 DBMET00627 0.105 0.071 DBMET02863 0.105 0.071 DBMET02864 0.138 0.04 DBMET02848 0.127 0.048 DBMET02851 0.127 0.048 DBMET02853 0.132 0.044 DBMET02856 | DBMET02848 | |
| 0.124 | 0.14 | 0.339 | Angiogenesis stimulant | 0.264 0.064 DBMET00627 0.136 0.131 DBMET02863 0.136 0.131 DBMET02864 0.136 0.132 DBMET02862 0.202 0.093 DBMET02848 0.247 0.071 DBMET02849 0.247 0.071 DBMET02850 0.233 0.078 DBMET02851 0.233 0.078 DBMET02853 0.215 0.087 DBMET02852 0.215 0.087 DBMET02854 0.339 0.036 DBMET02856 0.215 0.087 DBMET02857 0.326 0.04 DBMET02855 0.326 0.04 DBMET02858 | DBMET02856 | |
| 0.035 | 0.055 | 0.059 | Microtubule stabilization | 0.054 0.022 DBMET00627 0.042 0.039 DBMET02863 0.042 0.039 DBMET02864 0.05 0.028 DBMET02848 0.053 0.024 DBMET02849 0.053 0.024 DBMET02850 0.053 0.024 DBMET02851 0.053 0.024 DBMET02853 0.052 0.026 DBMET02852 0.052 0.026 DBMET02854 0.059 0.016 DBMET02856 0.052 0.026 DBMET02857 0.057 0.018 DBMET02855 0.057 0.018 DBMET02858 | DBMET02856 | |
| 0.017 | 0.038 | 0.022 | Vitamin D receptor antagonist | 0.021 0.018 DBMET02849 0.021 0.018 DBMET02850 0.021 0.017 DBMET02856 0.022 0.015 DBMET02855 0.022 0.015 DBMET02858 | DBMET02858 | |
| 0.079 | 0.104 | 0.103 | Bile acid receptor antagonist | 0.103 0.043 DBMET00627 0.096 0.057 DBMET02849 0.096 0.057 DBMET02850 0.092 0.068 DBMET02851 0.092 0.068 DBMET02853 0.102 0.045 DBMET02856 0.095 0.06 DBMET02855 0.095 0.06 DBMET02858 | DBMET00627 | |
| 0.014 | 0.039 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.016 DBMET02863 0.018 0.016 DBMET02864 0.018 0.016 DBMET02851 0.018 0.016 DBMET02853 | DBMET02853 | |
| 0.015 | 0.048 | 0.024 | Protein 30S ribosomal subunit inhibitor | 0.023 0.019 DBMET00627 0.024 0.016 DBMET02849 0.024 0.016 DBMET02850 0.022 0.02 DBMET02851 0.022 0.02 DBMET02853 0.023 0.018 DBMET02852 0.023 0.018 DBMET02854 0.022 0.02 DBMET02856 0.023 0.018 DBMET02857 0.024 0.017 DBMET02855 0.024 0.017 DBMET02858 | DBMET02858 | |
| 0.171 | 0.207 | 0.193 | Angiogenesis inhibitor | 0.193 0.178 DBMET02856 | DBMET02856 | |
| 0.01 | 0.05 | 0.019 | Telomerase stimulant | 0.017 0.013 DBMET02851 0.017 0.013 DBMET02853 0.019 0.009 DBMET02856 0.017 0.012 DBMET02855 0.017 0.012 DBMET02858 | DBMET02856 | |
| 0.113 | 0.156 | 0.155 | Pregnane X receptor agonist | 0.132 0.094 DBMET02860 0.132 0.094 DBMET02861 0.155 0.044 DBMET02862 0.138 0.079 DBMET02849 0.138 0.079 DBMET02850 0.136 0.083 DBMET02852 0.136 0.083 DBMET02854 0.134 0.089 DBMET02856 0.136 0.083 DBMET02857 0.151 0.052 DBMET02855 0.151 0.052 DBMET02858 | DBMET02862 | |
| 0.07 | 0.114 | 0.152 | Expectorant | 0.131 0.044 DBMET00627 0.088 0.083 DBMET02863 0.088 0.083 DBMET02864 0.152 0.034 DBMET02848 0.089 0.082 DBMET02849 0.089 0.082 DBMET02850 0.132 0.044 DBMET02851 0.132 0.044 DBMET02853 0.09 0.081 DBMET02852 0.09 0.081 DBMET02854 0.136 0.041 DBMET02856 0.09 0.081 DBMET02857 0.093 0.077 DBMET02855 0.093 0.077 DBMET02858 | DBMET02848 | |
| 0.079 | 0.124 | 0.121 | Amylase inhibitor | 0.121 0.08 DBMET00627 0.103 0.094 DBMET02849 0.103 0.094 DBMET02850 | DBMET00627 | |
| 0.077 | 0.126 | 0.123 | Acetylcholine muscarinic antagonist | 0.123 0.064 DBMET00627 0.11 0.079 DBMET02848 0.102 0.088 DBMET02849 0.102 0.088 DBMET02850 | DBMET00627 | |
| 0.025 | 0.08 | 0.05 | Potassium channel Kv1.3 blocker | 0.05 0.03 DBMET02859 0.047 0.033 DBMET02862 0.049 0.03 DBMET02848 | DBMET02859 | |
| 0.161 | 0.217 | 0.259 | Immunomodulator | 0.244 0.12 DBMET00627 0.205 0.158 DBMET02863 0.205 0.158 DBMET02864 0.203 0.16 DBMET02848 0.184 0.183 DBMET02849 0.184 0.183 DBMET02850 0.253 0.112 DBMET02851 0.253 0.112 DBMET02853 0.195 0.17 DBMET02852 0.195 0.17 DBMET02854 0.259 0.108 DBMET02856 0.195 0.17 DBMET02857 0.198 0.167 DBMET02855 0.198 0.167 DBMET02858 | DBMET02856 | |
| 0.048 | 0.12 | 0.101 | CDC25A inhibitor | 0.101 0.027 DBMET02856 0.097 0.029 DBMET02855 0.097 0.029 DBMET02858 | DBMET02856 | |
| 0.047 | 0.125 | 0.088 | Ornithine decarboxylase inhibitor | 0.088 0.058 DBMET02862 | DBMET02862 | |
| 0.027 | 0.114 | 0.12 | HIV-1 integrase (Strand Transfer) inhibitor | 0.093 0.025 DBMET02863 0.093 0.025 DBMET02864 0.12 0.017 DBMET02851 0.12 0.017 DBMET02853 0.059 0.042 DBMET02852 0.059 0.042 DBMET02854 0.059 0.042 DBMET02857 | DBMET02853 | |
| 0.056 | 0.143 | 0.116 | Breast cancer-resistant protein inhibitor | 0.116 0.042 DBMET00627 0.089 0.067 DBMET02848 0.086 0.071 DBMET02849 0.086 0.071 DBMET02850 0.094 0.061 DBMET02851 0.094 0.061 DBMET02853 | DBMET00627 | |
| 0.106 | 0.197 | 0.215 | Hypolipemic | 0.187 0.104 DBMET02860 0.187 0.104 DBMET02861 0.179 0.11 DBMET02863 0.179 0.11 DBMET02864 0.2 0.094 DBMET02862 0.175 0.114 DBMET02849 0.175 0.114 DBMET02850 0.148 0.139 DBMET02851 0.148 0.139 DBMET02853 0.215 0.085 DBMET02852 0.215 0.085 DBMET02854 0.215 0.085 DBMET02857 0.198 0.095 DBMET02855 0.198 0.095 DBMET02858 | DBMET02857 | |
| 0.066 | 0.162 | 0.101 | Cholinergic antagonist | 0.101 0.095 DBMET00627 | DBMET00627 | |
| 0.065 | 0.162 | 0.098 | Acetylcholine antagonist | 0.098 0.095 DBMET00627 | DBMET00627 | |
| 0.031 | 0.135 | 0.103 | HIV-1 integrase (3'-Processing) inhibitor | 0.09 0.03 DBMET02863 0.09 0.03 DBMET02864 0.103 0.025 DBMET02851 0.103 0.025 DBMET02853 | DBMET02853 | |
| 0.078 | 0.19 | 0.155 | Acetylcholine M1 receptor antagonist | 0.155 0.07 DBMET00627 0.121 0.107 DBMET02848 0.118 0.111 DBMET02849 0.118 0.111 DBMET02850 | DBMET00627 | |
| 0.134 | 0.246 | 0.239 | Peptidyltransferase inhibitor | 0.21 0.087 DBMET02860 0.21 0.087 DBMET02861 0.18 0.129 DBMET00627 0.172 0.142 DBMET02863 0.172 0.142 DBMET02864 0.22 0.076 DBMET02862 0.175 0.138 DBMET02848 0.237 0.061 DBMET02849 0.237 0.061 DBMET02850 0.172 0.142 DBMET02851 0.172 0.142 DBMET02853 0.23 0.067 DBMET02852 0.23 0.067 DBMET02854 0.181 0.127 DBMET02856 0.23 0.067 DBMET02857 0.239 0.059 DBMET02855 0.239 0.059 DBMET02858 | DBMET02858 | |
| 0.058 | 0.174 | 0.185 | Adenylate cyclase inhibitor | 0.169 0.034 DBMET00627 0.112 0.074 DBMET02848 0.185 0.029 DBMET02849 0.185 0.029 DBMET02850 0.105 0.08 DBMET02852 0.105 0.08 DBMET02854 0.15 0.045 DBMET02856 0.105 0.08 DBMET02857 0.164 0.037 DBMET02855 0.164 0.037 DBMET02858 | DBMET02850 | |
| 0.13 | 0.249 | 0.186 | Transcription factor STAT3 inhibitor | 0.186 0.155 DBMET02851 0.186 0.155 DBMET02853 | DBMET02853 | |
| 0.101 | 0.225 | 0.186 | Free radical scavenger | 0.156 0.138 DBMET00627 0.186 0.11 DBMET02849 0.186 0.11 DBMET02850 0.16 0.134 DBMET02855 0.16 0.134 DBMET02858 | DBMET02850 | |
| 0.1 | 0.236 | 0.387 | Tumour necrosis factor alpha release inhibitor | 0.173 0.132 DBMET02860 0.173 0.132 DBMET02861 0.291 0.057 DBMET00627 0.161 0.143 DBMET02862 0.315 0.048 DBMET02848 0.345 0.039 DBMET02849 0.345 0.039 DBMET02850 0.251 0.075 DBMET02851 0.251 0.075 DBMET02853 0.307 0.05 DBMET02852 0.307 0.05 DBMET02854 0.337 0.041 DBMET02856 0.307 0.05 DBMET02857 0.387 0.029 DBMET02855 0.387 0.029 DBMET02858 | DBMET02858 | |
| 0.072 | 0.249 | 0.109 | Interleukin 2 antagonist | 0.109 0.066 DBMET00627 0.104 0.078 DBMET02848 | DBMET00627 | |
| 0.082 | 0.269 | 0.2 | Non-steroidal antiinflammatory agent | 0.149 0.116 DBMET00627 0.2 0.071 DBMET02848 | DBMET02848 | |
| 0.018 | 0.216 | 0.052 | Alpha-mannosidase inhibitor | 0.05 0.043 DBMET02849 0.05 0.043 DBMET02850 0.052 0.039 DBMET02855 0.052 0.039 DBMET02858 | DBMET02858 | |
| 0.068 | 0.282 | 0.165 | Interleukin agonist | 0.165 0.153 DBMET02849 0.165 0.153 DBMET02850 | DBMET02850 | |
| 0.072 | 0.288 | 0.153 | Growth hormone agonist | 0.153 0.085 DBMET00627 0.137 0.099 DBMET02848 0.143 0.093 DBMET02849 0.143 0.093 DBMET02850 0.129 0.109 DBMET02851 0.129 0.109 DBMET02853 0.121 0.12 DBMET02852 0.121 0.12 DBMET02854 0.138 0.098 DBMET02856 0.121 0.12 DBMET02857 0.13 0.107 DBMET02855 0.13 0.107 DBMET02858 | DBMET00627 | |
| 0.006 | 0.232 | 0.035 | Farnesoid X receptor agonist | 0.035 0.031 DBMET02856 | DBMET02856 | |
| 0.097 | 0.353 | 0.34 | Antithrombotic | 0.252 0.124 DBMET00627 0.34 0.068 DBMET02849 0.34 0.068 DBMET02850 0.219 0.155 DBMET02851 0.219 0.155 DBMET02853 0.301 0.087 DBMET02852 0.301 0.087 DBMET02854 0.301 0.087 DBMET02857 0.25 0.126 DBMET02855 0.25 0.126 DBMET02858 | DBMET02850 | |
| 0.103 | 0.36 | 0.211 | Antiobesity | 0.211 0.196 DBMET02862 | DBMET02862 | |
| 0.144 | 0.412 | 0.349 | Calcium channel L-type activator | 0.349 0.118 DBMET02860 0.349 0.118 DBMET02861 0.317 0.143 DBMET02862 0.309 0.15 DBMET02849 0.309 0.15 DBMET02850 0.244 0.212 DBMET02852 0.244 0.212 DBMET02854 0.244 0.212 DBMET02857 0.248 0.207 DBMET02855 0.248 0.207 DBMET02858 | DBMET02861 | |
| 0.04 | 0.314 | 0.132 | Neurotrophic factor | 0.118 0.099 DBMET02849 0.118 0.099 DBMET02850 0.123 0.091 DBMET02851 0.123 0.091 DBMET02853 0.132 0.078 DBMET02852 0.132 0.078 DBMET02854 0.132 0.078 DBMET02857 0.117 0.101 DBMET02855 0.117 0.101 DBMET02858 | DBMET02857 | |
| 0.045 | 0.321 | 0.126 | Cytokine production inhibitor | 0.126 0.083 DBMET00627 | DBMET00627 | |
| 0.041 | 0.354 | 0.098 | Hedgehog signaling inhibitor | 0.098 0.067 DBMET02856 0.089 0.087 DBMET02855 0.089 0.087 DBMET02858 | DBMET02856 | |
| 0.026 | 0.384 | 0.152 | AMP-activated protein kinase stimulant | 0.125 0.045 DBMET00627 0.096 0.077 DBMET02848 0.152 0.027 DBMET02849 0.152 0.027 DBMET02850 0.1 0.071 DBMET02852 0.1 0.071 DBMET02854 0.11 0.058 DBMET02856 0.1 0.071 DBMET02857 0.138 0.036 DBMET02855 0.138 0.036 DBMET02858 | DBMET02850 | |
| 0.05 | 0.546 | 0.175 | Hypoglycemic | 0.175 0.14 DBMET02849 0.175 0.14 DBMET02850 0.162 0.16 DBMET02855 0.162 0.16 DBMET02858 | DBMET02850 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |